These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1227281)

  • 1. Leukocyte adherence inhibition. The detection of cellular responsiveness and serum 'blocking' factors in malignancy.
    Ablin RJ
    Allergol Immunopathol (Madr); 1975; 3(5):357-66. PubMed ID: 1227281
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro demonstration of cell-mediated immunity against human renal carcinoma assessed by the leukocyte migration assay.
    Pappas A; Schwarze G
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):142-50. PubMed ID: 4143237
    [No Abstract]   [Full Text] [Related]  

  • 3. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
    Cummings FJ; Heppner GH; Stolbach L; Calabresi P
    Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated immunity in prostatic cancer.
    Ablin RJ; Bhatti RA; Nagubadi S; Zamora S; Guinan PD
    Clin Oncol; 1980 Sep; 6(3):253-64. PubMed ID: 7428203
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic diagnosis of malignant neoplasms. I].
    Shuster J; Thomson DM; Fuks A; Gold P
    Union Med Can; 1980 Jun; 109(6):902-9. PubMed ID: 7008310
    [No Abstract]   [Full Text] [Related]  

  • 6. Historical background and aspects of the mechanism of leukocyte adherence inhibition.
    Halliday WJ
    Cancer Res; 1979 Feb; 39(2 Pt 2):558-63. PubMed ID: 367582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic approach to cancer.
    Mitchison NA
    Transplant Proc; 1970 Mar; 2(1):92-103. PubMed ID: 4107297
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental solid tumors: the role of macrophages and lymphocytes as effector cells.
    Haskill JS; Radov LA; Yamamura Y; Parthenais E; Korn JH; Ritter FL
    J Reticuloendothel Soc; 1976 Sep; 20(3):233-41. PubMed ID: 1086363
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary report of an immunological study in urological cancer.
    Serrallach N; Jimenez JF; Aguiló F; Anguera A; Clavo M; Orejas V; Torner V; Serrate R
    Eur Urol; 1975; 1(2):99-100. PubMed ID: 1241896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-induced, cell-mediated hypersensitivity in man. A critical review with special reference to leucocyte migration assays.
    Kjaer M
    Acta Allergol; 1976 Oct; 31(5):373-415. PubMed ID: 790887
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical applications of in vitro tests for cell-mediated immunity in liver diseases.
    Paronetto F; Vernace SJ; Colombo M
    Minerva Gastroenterol; 1976; 22(3):227-32. PubMed ID: 1087385
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated immunity.
    Valentine FT; Lawrence HS
    Adv Intern Med; 1971; 17():51-93. PubMed ID: 4147307
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental autoimmune uveitis: cellular immune responsiveness.
    Nussenblatt RB; Gery I; Wacker WB
    Invest Ophthalmol Vis Sci; 1980 Jun; 19(6):686-90. PubMed ID: 6966620
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of leukocyte migration by tumor-associated antigen and its modification by serum; IgA as a blocking factor.
    Sipos J; Gábor V; Tóth Z
    Neoplasma; 1978; 25(2):181-8. PubMed ID: 643122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotherapy].
    Lejeune FJ; Bernheim JL; Vanwijck R
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular immunity and blocking antibodies to tumors.
    Hellström I; Hellström KE
    J Reticuloendothel Soc; 1971 Jul; 10(1):131-6. PubMed ID: 5121177
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tumor immunology].
    Cerni CM
    Subsid Med; 1974; 2():21-5. PubMed ID: 4606048
    [No Abstract]   [Full Text] [Related]  

  • 18. Experiences with leukocyte adherence inhibition in human cancer.
    Maluish AE
    Cancer Res; 1979 Feb; 39(2 Pt 2):644-8. PubMed ID: 367590
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. IV. Leucocyte adherence inhibition.
    Ablin RJ; Bhatti RA; Guinan PD; Bruns GR
    Urol Int; 1976; 31(6):459-69. PubMed ID: 795128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factor.
    Ablin RJ; Bhatti RA; Bruns GR; Guinan PD
    Eur J Cancer (1965); 1977 Jul; 13(7):699-703. PubMed ID: 598395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.